X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
immunotherapy (18) 18
index medicus (17) 17
humans (16) 16
oncology (14) 14
article (11) 11
cancer (11) 11
aged (9) 9
male (9) 9
middle aged (9) 9
poster presentation (9) 9
female (8) 8
immunology (8) 8
metastasis (7) 7
adult (6) 6
analysis (6) 6
cancer vaccines - therapeutic use (6) 6
medicine & public health (6) 6
prostate cancer (6) 6
tumors (6) 6
colony-stimulating factor (5) 5
dendritic cells (5) 5
health aspects (5) 5
neoplasm metastasis (5) 5
patients (5) 5
resistant prostate-cancer (5) 5
aged, 80 and over (4) 4
brachyury (4) 4
cancer research (4) 4
cancer vaccines (4) 4
care and treatment (4) 4
cell biology (4) 4
immune response (4) 4
medical research (4) 4
neoplasms - immunology (4) 4
sipuleucel-t (4) 4
t cells (4) 4
vaccines (4) 4
antibodies, monoclonal - pharmacology (3) 3
antigen (3) 3
antineoplastic agents - pharmacology (3) 3
b7-h1 antigen - antagonists & inhibitors (3) 3
cancer vaccine (3) 3
carcinoembryonic antigen - immunology (3) 3
cell line, tumor (3) 3
chordoma (3) 3
clinical trials (3) 3
epithelial-mesenchymal transition (3) 3
flow cytometry (3) 3
gene expression (3) 3
immunoglobulins (3) 3
interferon-gamma - metabolism (3) 3
monoclonal antibodies (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
phenotype (3) 3
prostate-specific antigen - blood (3) 3
prostvac (3) 3
research (3) 3
research paper (3) 3
safety (3) 3
t-lymphocytes - immunology (3) 3
therapy (3) 3
treatment outcome (3) 3
tumor-infiltrating lymphocytes (3) 3
vaccine (3) 3
androgen receptor (2) 2
animals (2) 2
anti-pd-l1 (2) 2
antibody-dependent cell cytotoxicity - drug effects (2) 2
antibody-dependent cell-mediated cytotoxicity (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
biopsy (2) 2
blood (2) 2
breast neoplasms - pathology (2) 2
cancer immunotherapy (2) 2
cancer vaccines - adverse effects (2) 2
carcinoembryonic antigen - genetics (2) 2
cd4 antigen (2) 2
cd8 antigen (2) 2
cd8 t-cells (2) 2
cea (2) 2
checkpoint inhibitor (2) 2
chemical and pharmacologic phenomena (2) 2
chemotherapy (2) 2
chordoma - immunology (2) 2
chordoma - pathology (2) 2
clinical trial (2) 2
cohort studies (2) 2
dendritic cells - immunology (2) 2
disease progression (2) 2
disease-free survival (2) 2
diversified prime (2) 2
docetaxel (2) 2
enzyme-linked immunospot assay (2) 2
fda approval (2) 2
follow-up studies (2) 2
genetic aspects (2) 2
hemic and immune systems (2) 2
immunization (2) 2
immunoglobulin g (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 587 - 598
Journal Article
by Lundqvist, Andreas and van Hoef, Vincent and Zhang, Xiaonan and Wennerberg, Erik and Lorent, Julie and Witt, Kristina and Sanz, Laia Masvidal and Liang, Shuo and Murray, Shannon and Larsson, Ola and Kiessling, Rolf and Mao, Yumeng and Sidhom, John-William and Bessell, Catherine A and Havel, Jonathan and Schneck, Jonathan and Chan, Timothy A and Sachsenmeier, Eliot and Woods, David and Berglund, Anders and Ramakrishnan, Rupal and Sodre, Andressa and Weber, Jeffrey and Zappasodi, Roberta and Li, Yanyun and Qi, Jingjing and Wong, Philip and Sirard, Cynthia and Postow, Michael and Newman, Walter and Koon, Henry and Velcheti, Vamsidhar and Callahan, Margaret K and Wolchok, Jedd D and Merghoub, Taha and Lum, Lawrence G and Choi, Minsig and Thakur, Archana and Deol, Abhinav and Dyson, Gregory and Shields, Anthony and Haymaker, Cara and Uemura, Marc and Murthy, Ravi and James, Marihella and Wang, Daqing and Brevard, Julie and Monaghan, Catherine and Swann, Suzanne and Geib, James and Cornfeld, Mark and Chunduru, Srinivas and Agrawal, Sudhir and Yee, Cassian and Wargo, Jennifer and Patel, Sapna P and Amaria, Rodabe and Tawbi, Hussein and Glitza, Isabella and Woodman, Scott and Hwu, Wen-Jen and Davies, Michael A and Hwu, Patrick and Overwijk, Willem W and Bernatchez, Chantale and Diab, Adi and Massarelli, Erminia and Segal, Neil H and Ribrag, Vincent and Melero, Ignacio and Gangadhar, Tara C and Urba, Walter and Schadendorf, Dirk and Ferris, Robert L and Houot, Roch and Morschhauser, Franck and Logan, Theodore and Luke, Jason J and Sharfman, William and Barlesi, Fabrice and Ott, Patrick A and Mansi, Laura and Kummar, Shivaani and Salles, Gilles and Carpio, Cecilia and Meier, Roland and Krishnan, Suba and McDonald, Dan and Maurer, Matthew and Gu, Xuemin and Neely, Jaclyn and Suryawanshi, Satyendra and Levy, Ronald and Khushalani, Nikhil and Wu, Jennifer and Zhang, Jinyu and Basher, Fahmin and Rubinstein, Mark and Bucsek, Mark and Qiao, Guanxi and ...
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 11/2016, Volume 4, Issue S1
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 9/2013, Volume 62, Issue 9, pp. 1521 - 1531
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 42, pp. 69014 - 69023
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 25, pp. 37762 - 37772
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 3/2014, Volume 63, Issue 3, pp. 225 - 234
Yeast-CEA (GI-6207) is a therapeutic cancer vaccine genetically modified to express recombinant carcinoembryonic antigen (CEA) protein, using heat-killed yeast... 
Immunology | Medicine & Public Health | Yeast-CEA vaccine | Immunotherapy | Oncology | Cancer Research | Immunity | ELISPOT | Medullary thyroid cancer | IMMUNE-RESPONSE | HUMAN CARCINOEMBRYONIC ANTIGEN | HUMAN BREAST | COLONY-STIMULATING FACTOR | DENDRITIC CELLS | ANTITUMOR RESPONSES | IMMUNOLOGY | INDEPENDENT PROSTATE-CANCER | SIPULEUCEL-T | ONCOLOGY | COLORECTAL-CANCER | Follow-Up Studies | Saccharomyces cerevisiae - genetics | Humans | Middle Aged | Carcinoembryonic Antigen - genetics | Male | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Cancer Vaccines - therapeutic use | Neoplasm Metastasis | Colonic Neoplasms - immunology | Carcinoembryonic Antigen - therapeutic use | Injections, Subcutaneous | Aged, 80 and over | Adult | Female | Colonic Neoplasms - therapy | Cytokines - metabolism | Carcinoembryonic Antigen - immunology | Adenocarcinoma - immunology | Cells, Cultured | Treatment Outcome | Enzyme-Linked Immunospot Assay | Vaccines, DNA - therapeutic use | Genetic Engineering | Adenocarcinoma - therapy | Aged | CD8-Positive T-Lymphocytes - immunology | Genetic Vectors | Cancer vaccines | Autoimmunity | Thyroid cancer | Analysis | Vaccination | Genetically modified organisms | Clinical trials | Adults | Product development | Metastasis | T cells | Index Medicus | medullary thyroid cancer | immunity | CEA yeast vaccine | immunotherapy
Journal Article
Journal Article
JOURNAL FOR IMMUNOTHERAPY OF CANCER, ISSN 2051-1426, 09/2019, Volume 7, Issue 1, pp. 240 - 8
Background HuMax-IL8 (now known as BMS-986253) is a novel, fully human monoclonal antibody that inhibits interleukin-8 (IL-8), a chemokine that promotes tumor... 
HuMax-IL8 | SURVIVAL | Interleukin-8 (IL-8) | Solid tumor | CELLS | ANGIOGENESIS | Metastatic cancer | PROLIFERATION | Monoclonal antibody | IMMUNOLOGY | IL-8 | INTERLEUKIN-8 | BMS-986253 | Immune assays | EPITHELIAL-MESENCHYMAL TRANSITION | ONCOLOGY | Immunotherapy | BRACHYURY | Clinical trial | UP-REGULATION | EXPRESSION | Usage | Analysis | Stem cells | Clinical trials | Research | Interleukin-8 | Metastasis | Tumors
Journal Article